Pemetrexed–cisplatin combination in mesothelioma-Reference-Cited by-同舟云学术

Pemetrexed–cisplatin combination in mesothelioma

Published:2005-04 Issue:2 Volume:5 Page:231-237
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Reck Martin,Gatzemeier Ulrich

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737140.5.2.231

Reference48 articles.

1. Malignant pleural mesothelioma

2. Testa JR, Pass HI, Carbone M. Molecular biology of mesothelioma. In:Cancer: Principles and Practice of Oncology.Devita VT, Hellman S, Rosenberg SA (Eds), Lippincott Williams & Wilkins, PA, USA, 1937–1943 (2001).

3. The role of palliative radiotherapy in malignant mesothelioma

4. Physical aspects of external beam radiotherapy for the treatment of malignant pleural mesothelioma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemosensitivity of three patient-derived primary cultures of canine pericardial mesothelioma by single-agent and combination treatment;Frontiers in Veterinary Science;2023-11-02

2. Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target;Current Cancer Therapy Reviews;2017-11-15

3. Uncommon Thoracic Tumors;Clinical Radiation Oncology;2016

4. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed;Journal of Controlled Release;2015-12

5. Uncommon Thoracic Tumors;Clinical Radiation Oncology;2012